Pfizer snaps insulin marketing deal with Biocon

March 13th, 2012 - 10:45 pm ICT by IANS
Bangalore, March 13 (IANS) US drug major Pfizer Tuesday terminated its $350-million marketing alliance with Biocon Ltd to sell the leading Indian biotech firm's diabetes treatment insulin worldwide.As a result, ... Read more...

Posted in Business |